am 251 has been researched along with Jejunal Diseases in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YY | 1 |
| Li, YN | 1 |
| Ni, JB | 1 |
| Chen, CJ | 1 |
| Lv, S | 1 |
| Chai, SY | 1 |
| Wu, RH | 1 |
| Yüce, B | 1 |
| Storr, M | 1 |
1 other study available for am 251 and Jejunal Diseases
| Article | Year |
|---|---|
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus.
Topics: Analysis of Variance; Animals; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Electroph | 2010 |